Ipsen and Marengo Therapeutics announce strategic : vimarsan

Multi-year collaboration will sustain Ipsen’s presence in oncology by leveraging Marengo’s novel discovery of TCR Vβ-targeted precision T cell activation...

Related Keywords

United States , Saclay , France General , France , Cambridge , Cambridgeshire , United Kingdom , Massachusetts , China , Paris , Shanghai , American , Denise Reid Bashir , Howard Mayer , Ioana Piscociu , Ipsen Euronext , Zhen Su , Svetlana Makhni , Development Communications , Marengo Therapeutics Inc , Verge Scientific Communications , Marengo Therapeutics , Investigational New Drug , Executive Vice President , Rare Disease , With Specialty Care , Sponsored Level , American Depositary Receipt , Selectivet Cell Activation Repertoire , French Autorit , Des March , Registration Document , Global Media , Paris Stock Exchange Ipn , Ipsen Sa ,